The Safinamide Mesylate Market has seen significant growth in recent years, driven by an increasing prevalence of neurological disorders, particularly Parkinson's disease (PD). Safinamide mesylate is a drug that has emerged as a novel adjunctive therapy in the treatment of Parkinson's disease. It is an orally active, selective monoamine oxidase B (MAO-B) inhibitor that also exhibits...